Total Payments
$10,126
2024 Payments
$136.31
Companies
6
Transactions
29
Medicare Patients
555
Medicare Billing
$61,938
Payment Breakdown by Category
Consulting$8,085 (79.8%)
Food & Beverage$1,037 (10.2%)
Travel$990.35 (9.8%)
Education$13.17 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,085 | 2 | 79.8% |
| Food and Beverage | $1,037 | 23 | 10.2% |
| Travel and Lodging | $990.35 | 3 | 9.8% |
| Education | $13.17 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $9,367 | 7 | $0 (2023) |
| ABBVIE INC. | $339.00 | 16 | $0 (2024) |
| GENZYME CORPORATION | $299.52 | 3 | $0 (2019) |
| Biogen, Inc. | $93.57 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $13.33 | 1 | $0 (2019) |
| EMD Serono, Inc. | $13.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $136.31 | 5 | ABBVIE INC. ($136.31) |
| 2023 | $7,101 | 16 | Genentech USA, Inc. ($6,899) |
| 2021 | $2,435 | 1 | Genentech USA, Inc. ($2,435) |
| 2019 | $120.20 | 3 | GENZYME CORPORATION ($93.70) |
| 2018 | $188.28 | 2 | GENZYME CORPORATION ($94.71) |
| 2017 | $144.68 | 2 | GENZYME CORPORATION ($111.11) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $258.38 | General |
| Category: Immunology | ||||||
| 06/16/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $5,650.00 | General |
| Category: Immunology | ||||||
| 06/16/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $504.31 | General |
| Category: Immunology | ||||||
| 06/16/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $335.16 | General |
| Category: Immunology | ||||||
| 06/16/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $150.88 | General |
| Category: Immunology | ||||||
| 05/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Consulting Fee | Cash or cash equivalent | $2,435.00 | General |
| Category: Immunology | ||||||
| 09/30/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Education | In-kind items and services | $13.17 | General |
| Category: Neurology | ||||||
| 08/22/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $93.70 | General |
| 04/17/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 135 | 179 | $71,805 | $16,013 |
| 2022 | 3 | 135 | 170 | $72,035 | $15,775 |
| 2021 | 3 | 148 | 180 | $80,660 | $17,358 |
| 2020 | 4 | 137 | 162 | $69,385 | $12,792 |
Total Patients
555
Total Services
691
Medicare Billing
$61,938
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 119 | $44,625 | $9,366 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 42 | $20,790 | $4,837 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 18 | $6,390 | $1,811 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 97 | $36,375 | $7,521 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 54 | $26,730 | $6,088 | 22.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $8,930 | $2,166 | 24.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 78 | 97 | $48,015 | $10,480 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 67 | $25,125 | $5,025 | 20.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $7,520 | $1,853 | 24.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 73 | 94 | $46,530 | $8,223 | 17.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 29 | $10,875 | $1,711 | 15.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $7,810 | $1,604 | 20.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 28 | $4,170 | $1,253 | 30.0% |
About Katherine Destefano
Katherine Destefano is a Neurology healthcare provider based in North Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1639495559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katherine Destefano has received a total of $10,126 in payments from pharmaceutical and medical device companies, with $136.31 received in 2024. These payments were reported across 29 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($8,085).
As a Medicare-enrolled provider, Destefano has provided services to 555 Medicare beneficiaries, totaling 691 services with total Medicare billing of $61,938. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location North Haven, CT
- Active Since 04/16/2010
- Last Updated 12/03/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639495559
Products in Payments
- Ocrevus (Biological) $6,899
- OCREVUS (Biological) $2,435
- VRAYLAR (Drug) $339.00
- DISEASE STATE (Drug) $204.81
- LEMTRADA (Drug) $94.71
- TYSABRI (Biological) $93.57
- MAYZENT (Drug) $13.33
- Mavenclad (Biological) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in North Haven
Dr. Erin Longbrake, Md, MD
Neurology — Payments: $108,765
Neurology $108,765
Dr. David Pitt, Md, MD
Neurology — Payments: $16,264
Neurology $16,264
Adeniyi Fisayo, M.d, M.D
Neurology — Payments: $4,014
Neurology $4,014
Lori Cretella, Md, MD
Neurology — Payments: $1,034
Neurology $1,034
Dr. John Peters, Md, MD
Neurology — Payments: $24.46
Neurology $24.46